Siga Technologies Inc SIGA
We take great care to ensure that the data presented and summarized in this overview for SIGA TECHNOLOGIES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIGA
View all-
Black Rock Inc. New York, NY3.91MShares$26.2 Million0.0% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA3.16MShares$21.2 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$16.7 Million0.0% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA2.4MShares$16.1 Million1.51% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.35MShares$15.8 Million0.0% of portfolio
-
First Wilshire Securities Management Inc Pasadena, CA1.59MShares$10.6 Million2.94% of portfolio
-
American Century Companies Inc Kansas City, MO1.37MShares$9.18 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.16MShares$7.78 Million0.0% of portfolio
-
State Street Corp Boston, MA1.11MShares$7.42 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.05MShares$7.03 Million0.0% of portfolio
Latest Institutional Activity in SIGA
Top Purchases
Top Sells
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Transactions at SIGA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 01
2025
|
Daniel J Luckshire Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,346
-4.3%
|
$74,076
$6.49 P/Share
|
Jul 01
2025
|
Daniel J Luckshire Executive VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,193
+7.76%
|
-
|
Jul 01
2025
|
Dennis E Hruby EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,467
-5.19%
|
$62,802
$6.49 P/Share
|
Jul 01
2025
|
Dennis E Hruby EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+13.8%
|
-
|
Jun 10
2025
|
Gary J. Nabel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-9.15%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Gary J. Nabel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+23.36%
|
-
|
Jun 10
2025
|
Jaymie A Durnan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-7.38%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Jaymie A Durnan |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+19.74%
|
-
|
Jun 10
2025
|
Joseph W Marshall Iii |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-2.43%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Joseph W Marshall Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+7.5%
|
-
|
Jun 10
2025
|
Holly L. Phillips |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-9.15%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Holly L. Phillips |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+23.36%
|
-
|
Jun 10
2025
|
Julian Nemirovsky |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-9.15%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Julian Nemirovsky |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+23.36%
|
-
|
Jun 10
2025
|
Harold Eugene Ford Jr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,725
-15.74%
|
$34,350
$6.22 P/Share
|
Jun 10
2025
|
Harold Eugene Ford Jr. |
BUY
Exercise of conversion of derivative security
|
Direct |
19,084
+34.41%
|
-
|
Apr 18
2025
|
Larry R. Miller General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,532
-8.41%
|
$17,660
$5.99 P/Share
|
Apr 18
2025
|
Larry R. Miller General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,920
+14.15%
|
-
|
Mar 25
2025
|
Larry R. Miller General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,764
-7.31%
|
$13,820
$5.89 P/Share
|
Mar 25
2025
|
Larry R. Miller General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,920
+15.47%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 300K shares |
---|
Sale (or disposition) back to the issuer | 34.4K shares |
---|---|
Payment of exercise price or tax liability | 76.6K shares |